topic stringlengths 245 1.29k | doc stringlengths 52 16.9k | label stringclasses 3
values |
|---|---|---|
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lung Cancer Non Small Cell Lung Cancer Adenocarcinoma of Lung Participants are eligible to be included in the study only if all of the following apply Male and female participants who are at least 18 years of age on the day of signing the informed consent will be enrolled in the stud... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia New and existing patients seen for treatment of monoclonal B-cell lymphocytosis Any low grade lymphoproliferative disorder Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 12.0-999.0, Cystic Fibrosis Key Completed study drug treatment in parent study (VX18-445-104); or had study drug interruption(s) in parent study but completed study visits up to the last scheduled visit of the Treatment Period in the parent study Key History of study drug intolerance in parent ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-75.0, Cochlear Prosthesis Implantation Age between 18 and 75 years inclusive Use of the second CI for at least 1 year Regular follow-up in the Ear Nose and Throat department of Edouard Herriot Hospital in Lyon Post-lingual deafness Average voice recognition over 80% with 2 Cochlear Implants... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, CLL Transformation Ability to understand and the willingness to sign a written informed consent document 2. Signed Informed Consent 3. Confirmed diagnosis of chronic lymphocytic leukemia or small lymphocytic lymphoma as IW-CLL 2008 (Hallek et al, 2008) with biopsy proven transformati... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, B-ALL B-cell Non Hodgkin Lymphoma DLBCL Disease Status Disease Status of ALL Must have chemotherapy refractory disease defined as progression or stable disease after two lines of therapies, or relapsed disease after achieving CR Subjects with persistent or relapsed minimal residual d... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hemorrhoids, Internal Patients referred to proctologic consultation of Centro Hospitalar Universitário do Porto (CHUP) older than 18 years Clinical diagnosis of hemorrhoidal disease grade I, II and III (Goligher's classification) Refractory to conservative management (dietary modific... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Clonal Hematopoiesis of Indeterminate Potential Clonal Cytopenia of Undetermined Significance Participants with Clonal Hematopoiesis of Indeterminate Significance (CHIP) Greater than or equal to 18 years of age Willingness and capacity to provide written informed consent Presence of ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Prostate Cancer histological confirmation of prostatic adenocarcinoma, at least two symptomatic bone secondary lesions detected by bone scan and no known visceral metastases, except for malignant lymphadenopathy with less than 3 cm in the short axis diameter Eastern Cooperative Oncol... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Advanced Prostate Cancer Written informed consent 2. Age ≥18 years 3. Patients with APC with predominantly bone disease confirmed by bone scan (within 6 weeks) or CT (within 6 weeks), of starting treatment (Cycle 1 Day 1). Patients with local recurrence and bone metastases with an as... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 65.0-999.0, Lymphoid Leukemia Non-Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Histologically confirmed, non-17p del chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) with any of the three following conditions No prior CLL/SLL directed therapy and ... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma, B-Cell Lymphoma, Non-hodgkins Chronic Lymphocytic Leukemia B-Cell Chronic Lymphocytic Leukemia Patients must have any B-cell lymphoma, or CLL/SLL, Gray-zone lymphoma, nodular lymphocyte-predominant Hodgkin lymphoma, or classical Hodgkin lymphoma with any CD19 or CD20 expres... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Diffuse Large B Cell Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Leukemia Marginal Zone Lymphoma Men and women ≥ 18 years of age. 2. Patients must have histologic confirmation of relapsed or refractory lymphoma. 3. Baseline FDG-PET scans must demonstrate positive lesions ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Myeloid Neoplasm Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Initial presentation with > 10% myeloid blasts in peripheral blood or marrow and, after at least one course of induction treatment, now with > 5% blasts in peripheral blood or marrow, as assessed by m... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Leukemia, Lymphocytic, Chronic, B-Cell Patients with diagnosis of B-cell CLL 2. Disease status defined as refractory to or relapsed after at least one prior therapy. 3. Presence of measurable lymphadenopathy presence of > 1 nodal lesion 4. ECOG performance status ≤ 2. 5. Adequate bon... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Small Lymphocytic Leukemia (SLL) Chronic Lymphocytic Leukemia (CLL) Age greater than or equal to 18 years Diagnosis of CLL or SLL as defined by the following CLL: clonal B cells greater than or equal to 5,000 cells/uL in the peripheral blood SLL: lymphadenopathy with histopathologica... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-85.0, CLL/SLL ≥18 years of age. 2. Histologically confirmed chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) according to the 2018 international workshop (IW) CLL who must have relapsed or be refractory to at least one prior therapy for CLL/SLL and require treatment by... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, Helminthiasis Helminth Infection The included volunteer is a researcher within parasitology with focus on Trichuris trichiura and Trichiura suis. He planned to infect himself under medical supervision. This was his third self-infection with Trichuris. The only clinical criterion for h... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-75.0, Irritable Bowel Syndrome Patients who fulfil Rome IV for the diagnosis of IBS. 2. Patients were investigated to other gastrointestinal organic cause(s). 3. Moderate-to-severe IBS symptoms, as indicated by a score of ≥175 on the IBS Severity Scoring System (IBS-SSS) Pregnant or lactat... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Thoracic Surgery All consecutive patients admitted for lobectomy or wedge video-assisted thoracoscopy Opioid Free Anesthesia (OFA) administration was left to the discretion of the attending anesthetist according to his or her practices and habits age 18 or over lobectomy or wedge res... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Nonsmall Cell Lung Cancer Performance Status Patients must have histologically confirmed NSCLC that is metastatic or unresectable for which standard curative measures do not exist No prior systemic treatment with either chemotherapy or immunotherapy for non-curative intent. Patients ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Richter Transformation Confirmed diagnosis of CLL according to iwCLL (Hallek et al, 2018) 2. Confirmed histopathological diagnosis of RT 3. Creatinine clearance ≥30ml/min calculated according to the modified formula of Cockcroft and Gault or directly measured with 24hr urine collecti... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphocyte Depletion Willingness and ability to provide written informed consent and to comply with the study protocol. 2. Diagnosis of biopsy confirmed non-small cell lung cancer (NSCLC) with planned treatment with SBRT as definitive therapy OR imaging confirmed lung lesion for whic... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-99.0, COVID-19 COVID-19 Immunisation A subject must meet all of the following to be eligible to participate in this study: 1. Provides written informed consent prior to initiation of any study procedures. 2. Be able to understand and agrees to comply with planned study procedures and be ava... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-22.0, Acute Myeloid Leukemia All patients must be enrolled on APEC14B1 and consented to Screening (Part A) prior to enrollment and treatment on AAML1831. Submission of diagnostic specimens must be done according to the Manual of Procedures). Risk stratification will not be possible without t... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lung Cancer Mediastinal Lymphadenopathy Thoracic Cancer Patient age greater to or equal than 18 years old Receiving an endobronchial ultrasound for any diagnostic reason Patients under 18 years old Patient refuses consent to undergo endobronchial ultrasound or is incapable of decisi... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Anxiety Digital Eye Strain Grade 7 (12-13 years old) students in Duanzhou District, Zhaoqing city Students under home confinement and enrolled in online learning courses, during the COVID-19 outbreak Autism Spectrum Disorders and Pervasive Developmental Delay or Disorder Mental Retar... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Covid-19 Mental Health Disorder Stress Disorder Anxiety Depression SARS-CoV-2 Legal age Currently working on a health service that provides care to COVID-19 patients Give informed consent Inability to use electronic devices (required to complete the survey) | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-65.0, Low Back Pain Patients reported persistent LBP of more than 3/10 in the last 12 weeks Subjects with acute low back pain, "red flags" indicating signs of serious pathology, previous back surgery, pregnancy, specific rheumatological diseases, spodylolysis or spondylolisthesis, spinal t... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, COVID-19 Adult SARI patients with 2019-ncov infection confirmed by PCR; Absolute value of lymphocytes < 0. 6x 109/L; Severe respiratory failure within 48 hours and requires admission to ICU. (severe respiratory failure was defined as PaO2/FiO2 < 200 mmHg and was supported by positive ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, T-LGL Leukemia Clpd-Nk The gender of the patient is not limited, and the age is ≥18 years old; 2. Must meet diagnostic of T-LGLL or CLPD-NK according to WHO 2016 version; 3. The patient is treatment naive or received single methotrexate less than 4 weeks and without response. If rela... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-80.0, Cardiopulmonary Bypass Cardiac Surgery Patient weight ≤60kg Age ≥18 years old The patient underwent cardiac arrest surgery Heart transplant patients Emergency cardiac surgery patients Patients who had been assisted by extracorporeal membrane oxygenator (ECMO) or assisted by left hear... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Severe COVID-19 Disease Male or female participants ≥ 18 years of age. 2. Participants with SARS-CoV-2 infection, as defined by standard reverse transcriptase polymerase chain reaction (RT-PCR) assay or equivalent test. 3. Must have pulmonary infiltrate on radiologic examination. 4. ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Lymph Node Disease Ultrasound Therapy; Complications Patients with one of these four diseases Patients with severe heart and brain diseases and poor coagulation function. 2. Undiagnosed patients are not included in the statistical analysis. 3. Image distortion of CEUS acquisition can... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, Persistent Atrial Fibrillation Longstanding Persistent Atrial Fibrillation Diagnosed persistent and/or long-term Failed medical therapy with antiarrhythmic drug therapy Expected life expectancy of less than one year Previous heart operation Previous ablation procedure Left ventricula... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Metastatic Gastric Cancer Locally Advanced Gastric Adenocarcinoma Written informed consent obtained Age ≥ 18 years at time of study entry, no gender limit Participants must have histologically or cytologically confirmed adenocarcinoma of the stomach (including adenocarcinoma of the g... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, CLL/SLL Documented CLL or SLL requiring treatment according to IWCLL (appendix A) after at least (clinical) partial response as best response after the following initial study treatment: venetoclax-rituximab in HOVON 140/GAIA or venetoclax-obinutuzumab in HOVON 139/GIVE or HOVON 140/... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic, B-Cell Histologic documentation of disease: B-cell NHL or CLL requiring therapy; All participants must have relapsed or refractory disease with no other approved therapies available that would be more appropriate in the investigat... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 20.0-999.0, Jaw, Edentulous, Partially Diabetes ≥20 years Insulin-dependent diabetes with missing posterior maxillary tooth/teeth Residual bone height of the maxillary alveolar process between 4 and 7 mm Width of the alveolar process ≥6.5 mm Presence of mandibular occluding teeth Plasma glucose ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 1.0-30.0, Down Syndrome Recurrent B Acute Lymphoblastic Leukemia Patients must be >= 1 and < 31 years at time of enrollment Patients must have first relapse of CD19+ B-ALL (relapse blasts must express CD19) in one of the following categories Isolated bone marrow relapse Isolated central nervous ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Superficial Lymphadenopathy • Patients presented with enlarged lymph nodes by clinical examination Patients who previously receive any medical treatment or chemo or radiotherapy Patients who previously underwent fine needle aspiration cytology or biopsy | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Low Back Pain, Recurrent Included in the program Suffering from chronic low back pain (= low back pain installed for more than 2 months) Beneficiary of a social security For which his consent has been obtained in writing with regard to his participation in the protocol Bedridden or ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Knee Sprain (Mild) Knee Sprain (Moderate) Subject is aged ≥18 years old Subject has a recent mild (grade I) OR moderate (grade II) knee sprain The current condition of his/her knee allows the subject to resume usual physical activity Subject has been informed and is willing to sign a... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 20.0-999.0, Asthma; Eosinophilic Severe Asthma Late-Onset Asthma Key Written informed consent must be obtained at screening visit, before any assessment will be performed. Subjects should be able to provide informed written consent (study participation informed consent form): Able to give writte... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Diffuse Large B Cell Lymphoma histologically confirmed diagnosis of CD20+ DLBCL primary central nervous system lymphoma "double-hit" lymphoma | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hemophilia B Mucopolysaccharidosis I Mucopolysaccharidosis II Subjects who received SB-318 under Study Protocol SB-318-1502, SB-913 under Study Protocol SB-913-1602, or SB-FIX under Study Protocol SB-FIX-1501 2. Subjects who have provided consent to participate in the LTFU study Una... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-85.0, Endothelial Dysfunction We recruit individuals who were referred for a routine screening in the primary prevention outpatient clinic of Attikon University hospital History of Coronary artery disease History of Peripheral Arterial Disease History of Heart failure History of Stroke hep... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma, Non-Hodgkin Chronic Lymphocytic Leukemia Eastern Cooperative Oncology Group (ECOG) performance status grade of 0 or 1 Cardiac parameters within the following range: corrected QT interval (QTcF) <= 480 milliseconds Participants with B cell non-Hodgkin lymphoma (NHL) must hav... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia CLL/SLL Subject must be able to voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study specific procedures The time from diagnosi... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-45.0, Anthrax Anthrax Immunisation Provide written informed consent prior to initiation of any study procedures. 2. Understand and comply with planned study procedures, including completion of the electronic memory aid, and be available for all study visits. 3. Agree to the collection of ve... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Richter Syndrome Chronic Lymphocytic Leukemia Subject must have confirmed diagnosis of CLL based upon 2018 International Workshop on CLL (IwCLL) with biopsy proven Richter's Transformation to a DLBCL subtype Subject must be ≥18 years of age Subject must be able to sign informed conse... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Metastatic Prostate Neuroendocrine Carcinoma Metastatic Prostate Cancer Neuroendocrine-like prostate cancer, based on histology OR based on clinical presentation as defined by meeting one of the two below criteria. All subjects must submit their primary tumor or metastatic biopsy pat... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Signed informed consent form (ICF). Legally Authorized Representatives are permitted Ability and willingness to comply with requirements of the study protocol ≥ 18 years-old Have documented previously untreated CLL or SLL per WH... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Burkitt Lymphoma Patients must have histologically or cytologically confirmed B-cell lymphoma confirmed by the Laboratory of Pathology, NCI, as follows Aggressive B-cell lymphoma: includes DLBCL and subtypes, transformed lym... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-90.0, Lymphadenopathy Lung Cancer Sarcoidosis Tuberculosis Age >18 years at the time of the procedure Known or suspected lung cancer based on imaging (CT and/or PET/CT) Endosonography (EBUS and/or EUS) indicated for intrathoracic lymph node assessment/sampling according to national and inte... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-65.0, Lymphoma, Large B-Cell, Diffuse Transplantation Chemotherapy Male and female, aged 18-65; 2. newly-diagnosed high risk (aaipi 2-3 and aaipi 1 with large mass) DLBCL patients after autologous stem cell transplantation; 3. Laboratory tests (blood tests, liver and renal function) meet th... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, Carcinoma Breast Triple-negative Breast Cancer Invasive Ductal Carcinoma, Breast Aged from 18 to 70. 2. Histologically confirmed as breast invasive ductal carcinoma. 3. Molecular typing of breast lesions is triple-negative breast cancer, when the patient had multicentric lesions at th... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Acute Respiratory Failure Patient with acute respiratory failure table (SpO2 90% in ambient air or need more than 3 L/min of oxygen to have SpO2 > 92% AND/OR signs of respiratory struggle sign AND/OR respiratory rate control > 25 cycles/minute AND/OR cyanosis) Over 18 years old Preg... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 75.0-999.0, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Activated B-Cell Type Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation Diffuse ... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, CLL Progression All CLL patients CLL patients on treatment | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Must have a confirmed diagnosis of chronic lymphocytic leukemia or small lymphocytic lymphoma per IW-CLL 201814 requiring therapy based on at least one of the following as listed below Evidence of progressive marrow failure as m... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 20.0-75.0, B-cell Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma, Relapsed Non-Hodgkin's Lymphoma Refractory Primary Mediastinal Large B Cell Lymphoma Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma High-grade B-cell Lymphoma for Enrollment: A subject may participate ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Advanced Prostate Carcinoma born male diagnosed with advanced or metastatic prostate cancer able to read and speak English not born male not diagnosed with advanced or metastatic prostate cancer not able to read and speak English | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Generalized Epilepsy Infantile Spasms Metabolic Disease Partial Epilepsy Seizures Patients with partial seizures, infantile spasms and Lennox-Gastaut syndrome will be selected Evidence of a structural lesion as cause for epilepsy. Degenerative or metabolic disease. Inability to compl... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Partial Epilepsy Seizures Age 5 to 60 at entry to protocol. History of partial or Complex Partial Epilepsy for two or more years. Patients should be on a stable anti-convulsant regimen defined as unchanged medicines and dose modifications lower than 20% in the last month. Blood levels... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Drug/Agent Toxicity by Tissue/Organ Lymphoma Neutropenia Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Malignant solid tumor or lymphoma refractory to standard therapy or for which no therapy of proven benefit exists No leukemia Measurable or evaluable disea... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Heart Diseases Ventricular Arrhythmia Ventricular Fibrillation Death, Sudden, Cardiac Heart Arrest Patients with left ventricular dusfunction 2. Patients with non-ischemic cardiomyopathy Patients not at high risk for sudden cardiac death (SCD) | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 2.0-999.0, Epilepsy All patients older than 2 years referred to the Clinical Epilepsy Section will be included. DPA assignment for adults without consent capacity is required at the time of enrollment None | 2 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Epilepsy Seizure Cognition Disorders Subject must be diagnosed with partial seizures and/or secondary generalization or primary generalized seizures (absence, atonic, myoclonic, and generalized tonic-clonic seizures) Subjects must be on either carbamazepine, lamotrigine, phenytoin, or... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 21.0-75.0, Depression Epilepsy Must have a seizure disorder Must meet the DSM-IV for major depression Must be willing to provide written informed consent Must be age 21 to 75 years old Must be compliant, cooperative, reliable, and able to follow instructions, and to visit the clinic on schedule ... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Healthy of this study are normal adult volunteers who are greater than or equal to 21 years old are those who have either any medico-surgical, neurological and psychiatric illness, who have been taking any medication with potential influence on nervous system function; who have a pac... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Epilepsy Epileptic patients who are undergoing invasive recording with implanted subdural electrodes that cover the sensorimotor cortices. Therefore, we will recruit only those patients with medically intractable epilepsy who are candidates for surgical treatment, and in whom invasive... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 12.0-999.0, Epilepsy Epilepsy, Temporal Lobe Seizures Intractability: Two AEDs, one of which was either Dilantin, Tegretol, Carbatrol, or Trileptal used in appropriate doses, have failed due to inefficacy, not intolerance Frequency and Duration: Persistence of disabling seizures at 6 per year or... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-55.0, Schizophrenia Hallucinations Have persistent auditory hallucinations History of neurological disorder Serious, unstable medical conditions (persons with hypertension or diabetes mellitus may enroll if these conditions are treated and stable) Active drug or alcohol abuse (persons may ... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-45.0, Epilepsy Group A subjects will be 8 women between 18 and 45 years of age who have complex partial seizures with Type 1 catamenial seizure exacerbation as previously defined. Group B subjects will be 8 women between 18 and 45 years of age with complex partial seizures who do not meet t... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Dystonic Disorders Twenty healthy volunteers older than age 18 will be recruited for the study. Their gender, age, or ethnic origin will not provide bias for to the study. All subjects will sign an informed consent prior to participation in the trial for the trial will any current me... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Epilepsy Patients will be selected from the ERB, NINDS, NIH Epilepsy Clinic. Age 5 to 65 at entry to protocol. History of localization-related epilepsy for two or more years. Patients are on a stable anti-convulsant regimen defined as unchanged medicines and dose modifications lower t... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Dystonic Disorders Nineteen patients age 18 and over with focal dystonia of the upper limbs (writer's cramp) will be recruited for the study. For patients, the only selection are the presence of focal hand dystonia. Nineteen normal subjects age 18 and over will be recruited for the c... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 16.0-999.0, Epilepsy, Complex Partial Patient able and willing to give written informed consent or assent as appropriate in accordance with ICH and GCP guidelines Patient with newly diagnosed epilepsy who has complex partial seizures (with or without secondary generalization) Patient must have a... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 3.0-10.0, Partial Seizure Disorder Subject has diagnosis of partial seizures with/without secondary generalization, supported by Observed ictal events consistent with partial seizures: With/ without secondary generalization; Documented by reliable observers of following 2: EEG at some time in pa... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Epilepsy Patients older than 18 years of age. Patients of both sexes and any race or ethnicity who have intractable epilepsy who are deemed surgical candidates and accept epilepsy surgery Patients younger than 18 years of age. Pregnant women. Patients who are not surgical candidates... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Epilepsy Subjects of any race or ethnicity will be included in the study. Any subject who has been diagnosed with medically intractable epilepsy and is eligible for the epilepsy protocol #01-N-0139 will be evaluated for entry into this study All patients will have a seizure disorder a... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-65.0, Epilepsy Relevant and are listed below Partial-onset seizures with or without secondary generalization. The final determination shall be made by the Investigator based on a clinical description of the seizures and previous diagnostic testing that includes, at a minimum, video/clinica... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 12.0-65.0, Generalized Convulsive Epilepsy Subjects with a confirmed diagnosis consistent with idiopathic generalized epilepsy experiencing myoclonic seizures (IIB) that are classifiable according to the International Classification of Epileptic Seizures. To ensure an idiopathic generalized epil... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-65.0, Epilepsy, Partial Males/Females from 18 to 65 years of age (minimum body weight of 40 kg) Subjects with a confirmed diagnosis of epilepsy suffering from partial onset seizures whether or not secondarily generalized Subjects who have been treated for epilepsy for ≥6 months and are curr... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-65.0, Epilepsy, Partial Males/Females from 18 to 65 years of age (minimum body weight of 40 kg) Subjects with a confirmed diagnosis of epilepsy suffering from partial onset seizures whether or not secondarily generalized Subjects who have been treated for epilepsy for ≥6 months and are curr... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Congestive Heart Failure, Atrial Fibrillation Patient is willing and able to comply with the protocol Patient is willing to sign written informed consent Patient is expected to remain available for Follow-up visits Patient age is 18 years and older patient is on a stable medication r... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 4.0-65.0, Generalized Convulsive Epilepsy Subject with a confirmed diagnosis consistent with idiopathic generalized epilepsy experiencing primary generalized tonic-clonic seizures (IIE) that are classifiable according to the ILAE Classification of Epileptic Seizures Presence of at least 3 PGTC s... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-74.0, Epilepsy at screening Adult aged between 18 years and 74 years Focal epileptic seizures with or without secondary generalization Present treatment with one or two antiepileptic drugs (constant dosage during 8 weeks baseline phase prior to initiation of treatment with zonisamide). Stim... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 16.0-65.0, Epilepsy Male/female from 16 to 65 years Well-characterized focal epilepsy or epileptic syndrome according to the International League Against Epilepsy (ILAE) classification History of partial onset seizures Subjects having at least 4 partial onset seizures during the 4-week Baseline ... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 16.0-65.0, Epilepsy, Focal Well-characterized focal epilepsy or epileptic syndrome according to the International League Against Epilepsy (ILAE) classification Subjects with a history of partial onset seizures Subjects having at least 4 partial onset seizures during the Baseline period and at le... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Epilepsy Criteria:medically refractory partial epilepsy financial ability to pay for higher priced food - Low BMI | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-65.0, Epilepsy To be scheduled to undergo deep brain stimulation therapy (DBS) in an attempt to treat intractable epilepsy None | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 6.0-65.0, Epilepsy Medically intractable epilepsy Subjects undergoing neurosurgical operations requiring cortical mapping Subjects NOT undergoing neurosurgical operations requiring cortical mapping | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 16.0-49.0, Refractory Epilepsy Arrhythmia Sudden Death Refractory epilepsy Other pre-existing heart conditions | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 12.0-999.0, Epilepsies, Partial Patient has a diagnosis of partial seizures with onset before age 50, and the patient's prior electroencephalography and magnetic resonance imaging studies are consistent with the diagnosis of partial seizures Patient has at least 4 complex partial seizures, but l... | 1 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-75.0, Epilepsy Male or female patients aged 18-75. 2. Able and willing to give written informed consent in accordance with the ICH GCP Guidelines. 3. Female subjects of childbearing potential must not be pregnant (as confirmed by negative serum βHCG at screening and negative urine pregnancy... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 5.0-15.0, Epilepsy, Rolandic Subjects whose guardians submitted written consent Subjects with more than 2 seizures in last 1 year Subjects showing one of the following additional Psychological burden due to seizure Seizure in daytime More than 3 seizures in last 6 month Convulsive seizure Abnor... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 18.0-999.0, Seizures On Dilantin for seizure prophylaxis (dose determined by primary caregiver) with therapeutic Dilantin levels 2. Receiving enteral nutrition by the interrupted method at goal feeding rate 3. Age >18 4. Feeding tube in proper position, no restriction as to type of feeding tube ... | 0 |
41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity. Per outside medical patient was felt to have focal epilepsy with secondary generalization, likely due to... | eligible ages (years): 0.0-999.0, Epilepsy Seizures Epilepsies, Partial Epilepsy, Generalized Epilepsy, Tonic-Clonic Weigh >=25 kilograms Diagnosis of epilepsy within 3 months prior to study entry or recurrence of epilepsy while off of anit-epileptic drugs No more than two documented seizures during the three-month re... | 2 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.